Eastwood Bio-Medical Canada Second Quarter 2025 Earnings: CA$0.002 loss per share (vs CA$0.002 loss in 2Q 2024)

Simply Wall St · 5d ago

Eastwood Bio-Medical Canada (CVE:EBM) Second Quarter 2025 Results

Key Financial Results

  • Revenue: CA$76.8k (down 43% from 2Q 2024).
  • Net loss: CA$156.9k (loss widened by 21% from 2Q 2024).
  • CA$0.002 loss per share (in line with 2Q 2024).
earnings-and-revenue-history
TSXV:EBM Earnings and Revenue History July 2nd 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Eastwood Bio-Medical Canada's share price is broadly unchanged from a week ago.

Risk Analysis

You should always think about risks. Case in point, we've spotted 5 warning signs for Eastwood Bio-Medical Canada you should be aware of, and 4 of them can't be ignored.